Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment of Acute Cervical Spinal Cord Injury With Imatinib (Glivec®) - a Safety and Feasibility Study (EudraCT no 2014-002170-36)

NCT02363361 is registered in ClinicalTrials.gov with Professor Mikael Svensson, MD PhD as lead sponsor.

NCT NCT02363361
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02363361 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment of Acute Cervical Spinal Cord Injury With Imatinib (Glivec®) - a Safety and Feasibility Study (EudraCT no 2014-002170-36)
Lead sponsor
Professor Mikael Svensson, MD PhD
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2018
Completion date
December 31, 2021
Enrollment
10 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

cervical spinal cord injury